1. Home
  2. SLNG vs APLT Comparison

SLNG vs APLT Comparison

Compare SLNG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$4.15

Market Cap

92.0M

Sector

Utilities

ML Signal

N/A

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.11

Market Cap

18.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
APLT
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
18.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SLNG
APLT
Price
$4.15
$0.11
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$10.00
$1.25
AVG Volume (30 Days)
6.1K
9.9M
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$72,270,000.00
$1,000,000.00
Revenue This Year
$7.02
$124.18
Revenue Next Year
$7.68
$66.67
P/E Ratio
$79.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.29
$0.10
52 Week High
$8.28
$1.50

Technical Indicators

Market Signals
Indicator
SLNG
APLT
Relative Strength Index (RSI) 30.30 25.53
Support Level $4.26 $0.10
Resistance Level $4.90 $0.13
Average True Range (ATR) 0.22 0.02
MACD -0.08 0.02
Stochastic Oscillator 4.67 2.72

Price Performance

Historical Comparison
SLNG
APLT

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: